CEO Total Pay
$3.2M
FY2024 Summary Compensation, below median
CGC FY2024 SEC EDGAR DEF 14A
Canopy Growth Corp CEO pay ratio
The CEO earned $3.2M in FY2024 against median worker pay of $44,098 · Chemicals & Pharmaceuticals.
- State
- Z4
- Filing date
- 2025-08-07
- Industry
- Chemicals & Pharmaceuticals
- Fiscal year
- FY2024
Data updated August 2026
Subscribe to Canopy Growth Corp CEO pay filing updates (RSS)
CEO-to-worker pay ratio
73:1
Moderate (Scale: 0–1000:1)
CEO pay
$3.2M
Median worker
$44,098
Latest filing FY2024. This company's newest DEF 14A on file is for FY2024, not FY2025, so the figures on this page are from that earlier year and are not ranked against the FY2025 industry benchmark. Industry pages mark issuers like this one with a "Latest filing" label.
Answer first
Canopy Growth Corp reported a 73:1 CEO-to-worker pay ratio in FY2024 - above the Chemicals & Pharmaceuticals median of 42:1 across 168 filers.
Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.
- Pay ratio
- 73:1
- FY2024 disclosed
- CEO total
- $3.2M
- Summary Compensation Table total
- Median worker
- $44,098
- Dodd-Frank median employee
Ratio bands among Chemicals & Pharmaceuticals peers
Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.
CEO Compensation Breakdown, FY2024
A component-level pay breakdown is not reported in Canopy Growth Corp's structured SEC pay-ratio disclosure. See our methodology →
Filing-year trail · Canopy Growth Corp
Complete DEF 14A pay-ratio filings for this CIK across FY2021–2024. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).
- Latest ratio
- 73:1
- FY2024
- vs prior FY
- -92:1
- from FY2023 165:1
- CEO $ YoY
- -57%
- $3.2M latest
- Filings shown
- 4
- FY2021–2024
| FY | CEO pay | Δ pay | Median worker | Pay ratio | Δ ratio |
|---|---|---|---|---|---|
| 2021 | $4.5M | - | $46,827 | 97:1 | - |
| 2022 | $6.4M | +42% | $48,812 | 132:1 | +35:1 |
| 2023 | $7.6M | +17% | $45,864 | 165:1 | +33:1 |
| 2024 | $3.2M | -57% | $44,098 | 73:1 | -92:1 |
Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1737927, FY2021–2024. Adjacent-year deltas only.
Industry Comparison - Chemicals & Pharmaceuticals
This Company's Ratio
73:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$3.2M
Companies in Industry
168
vs. Industry Median
Above
Canopy Growth Corp: MODEST · MID$ pay ratio
Canopy Growth Corp disclosed 73:1 CEO-to-worker pay and $3.2M CEO total in FY2024. the CEO earned 73× the median employee ($44,098) in FY2024.
Median employee $44,098 (PAR-MED); MODEST · MID$ stamps put about 73 median-wage years per CEO year.
Pay Ratio
73:1
Near industry median
What FY2024 shows for Canopy Growth Corp
Canopy Growth Corp disclosed 73:1 CEO-to-worker pay and $3.2M CEO total in FY2024. The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Canopy Growth Corp's $3.2M CEO total is at or below the $7.9M industry median CEO pay.
Canopy Growth Corp stamps MODEST · MID$ · PAR-MED; grant-date fair value (not realized pay) is what the DEF 14A reports. Open Chemicals & Pharmaceuticals peers.
Key Data, FY2024
- Total Compensation
- $3.2M
- Median Employee Pay
- $44,098
- Pay Ratio
- 73:1
- Filing Date
- 2025-08-07
Company Info
- Ticker
- CGC
- CIK
- 1737927
- Industry
- Chemicals & Pharmaceuticals
- SIC Code
- 2833
- State
- Z4
SEC EDGAR DEF 14A for CIK 1737927, FY2024. Informational only, not investment advice. Verify on EDGAR.
Read our methodology - how this data is sourced, computed, and verified. Canopy Growth Corp disclosed 73:1 CEO-to-worker pay and $3.2M CEO total in FY2024.
Read with Canopy Growth Corp
ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MODEST · MID$ · PAR-MED.
Veritex Holdings, Inc. · MID$
ABS(ceo_total_comp) peer at $3.2M (Δ $846 heavier vs Canopy Growth Corp); MODEST · HIGH-MED vs this page's MODEST · MID$ · PAR-MED.
Rogers Corp · MID$
ABS(ceo_total_comp) peer at $3.2M (Δ $7K heavier vs Canopy Growth Corp); MODEST · PAR-MED vs this page's MODEST · MID$ · PAR-MED.
Motorcar Parts Of America Inc · MID$
ABS(ceo_total_comp) peer at $3.2M (Δ $13K heavier vs Canopy Growth Corp); STEEP · LOW-MED vs this page's MODEST · MID$ · PAR-MED.
Nicolet Bankshares Inc · MID$
ABS(ceo_total_comp) peer at $3.2M (Δ $27K lighter vs Canopy Growth Corp); MODEST · PAR-MED vs this page's MODEST · MID$ · PAR-MED.
Chemicals & Pharmaceuticals benchmark
Canopy Growth Corp stamps MODEST · MID$ · PAR-MED inside SIC 28 - open the industry median board after the ABS peers.
Pay-ratio rankings · MODEST
See where MODEST · MID$ packages sit on the national leaderboard after reading Canopy Growth Corp.
Ratio primer · MODEST
Canopy Growth Corp's MODEST stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for Canopy Growth Corp (CIK 1737927), FY2024. See our methodology. Aggregated by PlainCEOPay as of August 2026.
Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.